House Bill
|
1017
|
An Act to set standards for Attorney General review of provider practices
|
Support
|
$0.00
|
n/a
|
Senate Bill
|
2276
|
An Act relative to Risk Management and Own Risk and Solvency Assessment
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
905
|
An Act to Expand Coverage and Access to Behavioral Health Services
|
Oppose
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Division of Insurance regarding Risk Adjustment
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
3460
|
An Act requiring insurance providers cover a minimum of 30 days for in-patient substance abuse treatment
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
541
|
An Act concerning out-of-pocket expenses for prescription drug coverage
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
913
|
An Act concerning the safety of autistic and alzheimer individuals
|
Oppose
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Division of Insurance Regarding Draft Bulletin on Standard Quality Measure Set
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
1034
|
An Act ensuring parity for mental health and substance abuse treatment
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
3488
|
An Act providing for certain health insurance coverage
|
Oppose
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Division of Insurance regarding premium rate informational session
|
Neutral
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Massachusetts Health Connector regarding 1332 Innovation Waiver
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
828
|
An Act Relative to Patient Financial Protection
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
635
|
An Act regarding shared responsibility for funding of health care oversight agencies
|
Support
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Administration and Finance regarding Changes to Quarterly Rate Filings Due to the Affordable Care Act
|
Neutral
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Department of Public Health regarding Mobile Integrated Health Regulations
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
956
|
An Act relative to Lyme Disease treatment coverage
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
1165
|
An Act relative to the dispensing of certain cancer related drugs
|
Oppose
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Center for Health Information and Analysis regarding All Payer Claims Database Data Release
|
Neutral
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Health Policy Commission regarding Prescription Drug Costs
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
901
|
An Act relative to Lyme disease treatment coverage
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
1577
|
An Act relative to gender identity and nondiscrimination
|
Support
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Administration and Finance regarding Changes to the State's Small Group Definition Due to the Affordable Care Act
|
Neutral
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Health Policy Commission on Annual Trends Cost Hearings
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
975
|
An Act to Contain Health Care Costs by Reducing Fraudulent Billing Practices
|
Support
|
$0.00
|
n/a
|
House Bill
|
3931
|
An Act Massachusetts Fair Health Care Pricing Act
|
Neutral
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Center for Health Information and Analysis and the Division of Insurance regarding Proposed Regulations for Premium and Claims Data Reporting
|
Neutral
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Health Policy Commission regarding Surprise Billing
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
813
|
An Act relative to payment for use of ambulance services
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
613
|
An Act relative to review of provider material changes
|
Support
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Administration and Finance regarding 1332 Innovation Waiver
|
Neutral
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Governor's Office regarding Changes to the State's Small Group Definition Due to the Affordable Care Act
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
1016
|
An Act strengthening Market Impact Review
|
Support
|
$0.00
|
n/a
|
Senate Bill
|
502
|
An Act relative to Lyme Disease treatment coverage
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
792
|
An Act Relative to Ensuring Transparency of Health Plan Formularies
|
Oppose
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Division of Insurance regarding the Definition of Full-Time Employee Under the Affordable Care Act
|
Neutral
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Division of Insurance regarding Guidance on the Submission of Policy Form and Rate Filing Materials
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
2020
|
An Act relative to substance abuse prevention
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
2137
|
An Act Relative to coverage of HIV-Associated lipodystrophy treatment
|
Oppose
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Division of Insurance on Sessions regarding Bulletin on Common Summary of Payments Form
|
Neutral
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Division of Insurance regarding regulatory reform initiative
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
791
|
An Act relative to patient medication adherence
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
596
|
An Act safeguarding consumer parity rights
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
930
|
An Act relative to the practice of acupuncture
|
Oppose
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Governor's Office regarding Changes to the State Rating Factors Due to the Affordable Care Act
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
483
|
An Act relative to women’s health and economic equity
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
267
|
An Act advancing and expanding access to telemedicine services
|
Oppose
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Division of Insurance regarding Changes to the State's Small Group Definition Due to the Affordable Care Act
|
Neutral
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Division of Insurance regarding accreditation filing bulletin
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
948
|
An Act relative to women’s health and economic equity
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
579
|
An Act to provide Medicare for All
|
Oppose
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Center for Health Information and Analysis on Mandate Reviews
|
Neutral
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Health Policy Commission regarding patient centered medical home certification
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
4201
|
An Act making appropriations for the fiscal year two thousand seventeen for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
557
|
An Act to protect access to confidential healthcare
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
1502
|
An Act Providing Access to Full Spectrum of Addiction Treatment Services
|
Oppose
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Governor's Office regarding Changes to Quarterly Rate Filings Due to the Affordable Care Act
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
871
|
An Act to protect access to confidential healthcare
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
735
|
An Act Relative to Transgender Anti-Discrimination
|
Support
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Administration and Finance regarding Changes to the State Rating Factors Due to the Affordable Care Act
|
Neutral
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Health Policy Commission on Accountable Care Organization Certification Standards
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
1048
|
An Act to promote transparency and cost control of pharmaceutical drug prices
|
Support
|
$0.00
|
n/a
|
Senate Bill
|
1154
|
An Act relative to full application of telemedicine coverage
|
Oppose
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Division of Insurance on Administrative Simplification, Uniform Prior Authorization Forms
|
Neutral
|
$0.00
|
n/a
|
Executive
|
|
Discussions with Administration and Finance regarding regulatory reform initiative
|
Neutral
|
$0.00
|
n/a
|
| | |
Total amount
|
$0.00
| |